4//SEC Filing
ACORDA THERAPEUTICS INC 4
Accession 0001209191-15-071986
CIK 0001008848operating
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 4:23 PM ET
Size
11.1 KB
Accession
0001209191-15-071986
Insider Transaction Report
Form 4
Blight Andrew
Chief Scientifc Officer
Transactions
- Exercise/Conversion
Common Stock
2015-09-21$6.00/sh+13,085$78,510→ 84,744 total - Sale
Common Stock
2015-09-21$31.81/sh−6,191$196,966→ 71,659 total - Sale
Common Stock
2015-09-21$30.85/sh−6,894$212,646→ 77,850 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-09-21−13,085→ 0 totalExercise: $6.00Exp: 2016-02-15→ Common Stock (13,085 underlying)
Footnotes (4)
- [F1]Exercise and sales pursuant to a 10b5-1 plan. Dr. Blight exercised 13,085 stock options, all of which were due to expire 2/15/2016 unless exercised.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $30.56 to $31.26 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $31.29 to $32.29 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The shares subject to these options vested in installments and were fully vested on 2/15/2010.
Documents
Issuer
ACORDA THERAPEUTICS INC
CIK 0001008848
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001008848
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 4:23 PM ET
- Size
- 11.1 KB